| scholarly article | Q13442814 |
| P50 | author | Stephen T. Holgate | Q1547900 |
| P2093 | author name string | A Papi | |
| S L Johnston | |||
| N G Papadopoulos | |||
| K Degitz | |||
| L A Stanciu | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | loratadine | Q424049 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 221-228 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells | |
| P478 | volume | 108 |
| Q35878377 | Anti-inflammatory properties of desloratadine |
| Q36692425 | Antimicrobial strategies: an option to treat allergy? |
| Q35546007 | Asthma and rhinosinusitis |
| Q42471038 | Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor. |
| Q35054259 | Desloratadine: a nonsedating antihistamine |
| Q35214559 | Desloratadine: an update of its efficacy in the management of allergic disorders |
| Q34623813 | Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines |
| Q44173557 | Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis |
| Q35552822 | H1-receptors: localization and role in airway physiology and in immune functions |
| Q39979447 | Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms |
| Q35218066 | Host defense function of the airway epithelium in health and disease: clinical background |
| Q34987195 | IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. |
| Q35846705 | Mechanisms of rhinovirus-induced asthma |
| Q40468074 | Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. |
| Q38864963 | Review of Methods to Study Gene Expression Regulation Applied to Asthma |
| Q34544512 | Second-generation antihistamines in asthma therapy: is there a protective effect? |
| Q36019822 | Second-generation antihistamines: actions and efficacy in the management of allergic disorders |
| Q107073292 | Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis |
| Q35827475 | The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine |
| Q34567414 | The H1 histamine receptor regulates allergic lung responses. |
| Q89935334 | The Roles of ORMDL3 in Rhinovirus Infections |
| Q46740448 | The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: a placebo-controlled randomized study |
| Q36331872 | The safety and efficacy of desloratadine for the management of allergic disease |
Search more.